Indications for Antifibrinolytic Therapy
- 1 January 1975
- journal article
- research article
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 34 (03), 634-643
- https://doi.org/10.1055/s-0038-1651453
Abstract
* Presented at the Postgraduate Course and Workshop “Progress in Fibrinolysis”, Milan, March 6–8, 1975.This publication has 11 references indexed in Scilit:
- INHIBITION OF THROMBOPLASTIC ACTIVITY BY TRASYLOL - IN VITRO INVESTIGATIONS CONCERNING MECHANISM OF INHIBITION1967
- The Use of EACA in Preventing or Reducing Hemorrhages in the HemophiliacThrombosis and Haemostasis, 1967
- Epsilon Amino Caproic Acid Therapy as a Cause of Intrarenal Obstruction in Haematuria of HaemophiliacsScandinavian Journal of Haematology, 1965
- THE USE OF EPSILON-AMINOCAPROIC ACID IN THE MANAGEMENT OF DENTAL EXTRACTIONS IN THE HEMOPHILIACThe American Journal of the Medical Sciences, 1964
- Thrombotic State after a Hemorrhagic Diathesis, a Possible Complication of Therapy with Epsilon-Aminocaproic AcidBlood, 1962
- Reduction of Postprostatectomy Bleeding by Epsilon-Aminocaproic AcidNew England Journal of Medicine, 1962
- Clinical Experiences with ε‐Aminocaproic Acid (ε‐ACA) as an Antifibrinolytic AgentActa Medica Scandinavica, 1961
- EPSILON-AMINOCAPROIC ACID - INHIBITOR OF PLASMINOGEN ACTIVATION1959
- Plasminogen Activator in Animal Meninges.Experimental Biology and Medicine, 1958
- OBSERVATIONS ON FIBRINOLYSIS EXPERIMENTAL ACTIVITY PRODUCED BY EXERCISE OR ADRENALINEThe Lancet, 1947